Gut Microbiota and Health: A Review With Focus on Metabolic and Immunological Disorders and Microbial Remediation by Pradhan, Biswaranjan et al.
 
 to  
. . .in
Biomedical Reviews
GUT MICROBIOTA AND HEALTH: A REVIEW WITH FOCUS ON METABOLIC 
AND IMMUNOLOGICAL DISORDERS AND MICROBIAL REMEDIATION  
Biswaranjan Pradhan1, David Datzkiw2, and Palok Aich1 
r
2






Biomed Rev 27, 2016

































Biomed Rev 27, 2016
Pradhan, Datzkiw and Aich
Box 1. Important terms
Microbiota
The types of microorganisms that are present in a habitat; including 
bacteria, viruses and eukaryotes.
Microbiome
A collection of different microbes found in a given habitat and 
their collective gene functions.  For example, skin microbiome, gut 
microbiome etc.
Metagenomics
A method which allows us to create catalogues of what the 
microbiome can do as a single unit based on the collective genes 
they have.
Dysbiosis
A disturbance or imbalance in a biological system, for example, 
changes in the types and numbers of bacteria in the gut which may 
lead to developing different diseases, such as inflammatory bowel 
disease.
Pathobiont
A commensal organism that can cause disease when specific 
genetic or environmental conditions are altered in the host.
Prebiotics
A selectively fermented ingredient that results in specific changes 
in the composition and/or activity of the gut microbiota, thus 
conferring benefits upon host health.
Probiotics
Live microorganisms that, when administered in adequate amounts, 
confer a health benefit on the host. Examples include strains of the 
genera Bifid bacterium and Lactobacillus. 
Fecal microbial transplantation
The introduction of gut bacteria from a healthy donor into a patient, 
through transfer of an infusion of a fecal sample via administration 
through nasal, oral, or rectal tubes.
Diabetes and the gut microbiota
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Table 1.  
disease
Disease Taxonomic changes in disease state microbiota
Obesity High Firmicute-Bacteroides ratio
Lower butyrate bacteria related to Roseburia intestinalis
Type 2 
diabetes
Lower class Clostridia and phylum Firmicutes
High ratio of Bacteroides-Firmicutes; +ve correlation with 
blood glucose concentration




High ratio of Bacteroides-Firmicutes; +ve correlation with 
blood glucose concentration
Increase in Bacteroides populationz
Increase in Veillonella and Clostridium
Decrease in Lactobacillus, Bifidobacterium, Blautia 
coccoides/Eubacterium rectale group and Prevotella
Colorectal 
cancer
Increase in Bacteroides, Odoribacter, and Allobaculum 
genera
Decrease in Prevotellaceae and Porphyromonadaceae 
families
Increase in Bacteroides fragilis and Bacteroides fragilis 
toxin
Increase in Enterobacteriaceae
Increase in Streptococcus gallolyticus, Enterococcus 
faecalis and Bacteroides fragilis 





Increased Clostridium, Dorea, and Ruminococcus,
Decreased Bifidobacterium, Faecalibacterium and 
methanogens
Decrease in Roseburia, E. rectale, H2-consuming 




Increased Actinobacteria and Proteobacteria
Increased Candida, Penicillium and Saccharomyces
Decreased Bacteroidetes and Lachnospiraceae
Crohn’s disease specific changes
Increase in Ruminococcus gnavus
Decrease in Dialister invisus, Faecalibacterium prausnitzii 
and Bifidobacterium adolescentis
Ulcerative colitis specific changes
Increased Escherichia sp, Helicobacter sp, Campylobacter 
sp, and Pseudomonas aeruginosa
Decreased Firmicutes and Bacteroidetes
Decreased Clostridium coccoides, Clostridium leptum, 
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Evidence based claim References
Escherichia coli Nissle Liver cirrhosis Restores More Bifidobacteria and
Lactobacillus
(111)
Saccharomyces boulardii lyo Active diarrhoea Improves More ‘habitual microbiota’ (112) 
Lactobacillus plantarum 8PA3
+ Bifidobacterium bifidum
Colon cancer Restores More E. coli and
enterococci
(113) 
L. brevis CD2+Lactobacillus salivaris FV2+L. plantarum FV9 L. 
paracasei Lpc37+L. acidophilus 74-2+Bifido animalis DGCC420
IBS Restores More clostridia
and Ruminococcus
(114, 115)
L. rhamnosus GG+L. rhamnosus
Lc705+Propionibacterium freudenreichii shermanii JS+B.
breve Bb99
IBS Restores More clostridia (116-118)
L. acidophilus 4356+L. plantarum
14917+L. rhamnosus 7469












IBS Altered Less bacteroides (120)
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CONCLUSION -
Figure 1. Change in healthy microbial composition leads to dysbiosis (red arrows) and is associated with obesity, diabetes, 
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